{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:58:47Z","timestamp":1777705127119,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bcmd.2021.102612","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T02:43:33Z","timestamp":1632192213000},"page":"102612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort"],"prefix":"10.1016","volume":"92","author":[{"given":"Crawford","family":"Strunk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Immacolata","family":"Tartaglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie M.","family":"Piccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Colombatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biree","family":"Andemariam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Manwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashya","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haikel","family":"Haile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia Vicky","family":"Asare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Rivers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatimah","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekah","family":"Urbonya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Boruchov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gifty Dankwah","family":"Boatemaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silverio","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivy","family":"Ekem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Sainati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Zempsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredericka","family":"Sey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Antwi-Boasiako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Segbefia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baba","family":"Inusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4 Suppl","key":"10.1016\/j.bcmd.2021.102612_bb0005","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am. J. Prev. Med."},{"issue":"16","key":"10.1016\/j.bcmd.2021.102612_bb0010","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"10091","key":"10.1016\/j.bcmd.2021.102612_bb0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.bcmd.2021.102612_bb0020","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pain.2009.06.029","article-title":"Pain site frequency and location in sickle cell disease: the PiSCES project","volume":"145","author":"McClish","year":"2009","journal-title":"Pain"},{"issue":"23","key":"10.1016\/j.bcmd.2021.102612_bb0025","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.bcmd.2021.102612_bb0030","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1182\/bloodadvances.2019000882","article-title":"End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain","volume":"3","author":"Farrell","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.bcmd.2021.102612_bb0035","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia [Internet]","volume":"332","author":"Charache","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bcmd.2021.102612_bb0040","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1512021","article-title":"A multinational trial of prasugrel for sickle cell vaso-occlusive events","volume":"374","author":"Heeney","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bcmd.2021.102612_bb0045","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bcmd.2021.102612_bb0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1715971","article-title":"A phase 3 trial of l-glutamine in sickle cell disease","volume":"379","author":"Niihara","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bcmd.2021.102612_bb0055","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.bcmd.2021.102612_bb0060","series-title":"NHS Sickle Cell and Thalassaemia Screening Programme, Sickle Cell Society. Sickle Cell Disease in Childhood: Standards and Guidelines for Clinical Care","author":"Dick","year":"2010"},{"issue":"8","key":"10.1016\/j.bcmd.2021.102612_bb0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1750-1172-8-169","article-title":"Organizing national responses for rare blood disorders: the Italian experience with sickle cell disease in childhood","volume":"20","author":"Colombatti","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"11","key":"10.1016\/j.bcmd.2021.102612_bb0070","article-title":"Geographic differences in phenotype and treatment of children with sickle cell anemia from the multinational DOVE study","volume":"8","author":"BPD","year":"2019","journal-title":"J. Clin. Med. Res."},{"issue":"6","key":"10.1016\/j.bcmd.2021.102612_bb0075","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/bjh.15250","article-title":"Novel findings from the multinational DOVE study on geographic and age-related differences in pain perception and analgesic usage in children with sickle cell anaemia","volume":"184","author":"Kanter","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.bcmd.2021.102612_bb0080","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00277-020-04057-8","article-title":"A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis","volume":"99","author":"Antwi-Boasiako","year":"2020","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2021.102612_bb0085","article-title":"An analysis of racial and ethnic backgrounds within the CASiRe International Cohort of Sickle Cell Disease Patients: implications for disease phenotype and clinical research","author":"Campbell","year":"2020","journal-title":"J. Racial Ethn. Health Disparities"},{"key":"10.1016\/j.bcmd.2021.102612_bb0090","first-page":"32","article-title":"Evidence-based management of sickle cell disease","author":"Buchanan","year":"2014","journal-title":"CreateSpace"},{"key":"10.1016\/j.bcmd.2021.102612_bb0095","article-title":"Relation between religious perspectives and views on sickle cell disease research and Associated Public Health Interventions in Ghana","author":"Dennis-Antwi","year":"2018","journal-title":"J. Genet. Couns."},{"issue":"12","key":"10.1016\/j.bcmd.2021.102612_bb0100","article-title":"International differences in outpatient pain management: a survey of sickle cell disease","volume":"8","author":"El-Amin","year":"2019","journal-title":"J. Clin. Med. Res."},{"issue":"88","key":"10.1016\/j.bcmd.2021.102612_bb0105","article-title":"Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort","volume":"2","author":"Tartaglione","year":"2021","journal-title":"Blood Cells Mol. Dis."},{"issue":"1","key":"10.1016\/j.bcmd.2021.102612_bb0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/AJP.0b013e318245764b","article-title":"The management of sickle cell pain in the emergency department: a priority for health systems","volume":"29","author":"Po\u2019","year":"2013","journal-title":"Clin. J. Pain"},{"issue":"6","key":"10.1016\/j.bcmd.2021.102612_bb0115","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.drugpo.2014.07.009","article-title":"Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons","volume":"25","author":"Weisberg","year":"2014","journal-title":"Int. J. Drug Policy"},{"issue":"4","key":"10.1016\/j.bcmd.2021.102612_bb0120","first-page":"370","article-title":"Opioids prescriptions in pain therapy and risk of addiction: a one-year survey in Italy. Analysis of national opioids database","volume":"54","author":"Miceli","year":"2018","journal-title":"Ann. Ist. Super. Sanita"},{"issue":"3","key":"10.1016\/j.bcmd.2021.102612_bb0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s41256-018-0087-6","article-title":"Trends and characteristics of enrolment in the National Health Insurance Scheme in Ghana: a quantitative analysis of longitudinal data","volume":"13","author":"Nsiah-Boateng","year":"2018","journal-title":"Glob. Health Res. Policy"},{"issue":"7","key":"10.1016\/j.bcmd.2021.102612_bb0130","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/heapol\/czt074","article-title":"Does the distribution of healthcare utilization match needs in Africa?","volume":"29","author":"Bonfrer","year":"2014","journal-title":"Health Policy Plan."},{"key":"10.1016\/j.bcmd.2021.102612_bb0135","unstructured":"Website [Internet]. [cited 2021 Jul 2]. Available from: https:\/\/isser.ug.edu.gh\/emergency-medical-care-ghana-focus-national-ambulance-service-support-systems-and-beds-healthcare."},{"issue":"2","key":"10.1016\/j.bcmd.2021.102612_bb0140","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcmd.2021.102612_bb0145","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1056\/NEJMp2022125","article-title":"When actions speak louder than words \u2014 racism and sickle cell disease [internet]","volume":"383","author":"Power-Hays","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.bcmd.2021.102612_bb0150","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/j.socscimed.2010.03.010","article-title":"Disclosure and sickle cell disorder: a mixed methods study of the young person with sickle cell at school","volume":"70","author":"Dyson","year":"2010","journal-title":"Soc. Sci. Med."},{"issue":"1","key":"10.1016\/j.bcmd.2021.102612_bb0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pedhc.2020.08.002","article-title":"Caregiver perception of sickle cell disease stigma in Ghana: an ecological approach","volume":"35","author":"Buser","year":"2021","journal-title":"J. Pediatr. Health Care"},{"issue":"10223","key":"10.1016\/j.bcmd.2021.102612_bb0160","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(19)33019-3","article-title":"Improving the prognosis of health care in the USA","volume":"395","author":"Galvani","year":"2020","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.bcmd.2021.102612_bb0165","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1002\/hec.1035","article-title":"The italian health-care system","volume":"14","author":"France","year":"2005","journal-title":"Health Econ."},{"issue":"5","key":"10.1016\/j.bcmd.2021.102612_bb0175","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/03007995.2019.1585168","article-title":"Tramadol: a valuable treatment for pain in Ghana and Nigeria","volume":"35","author":"Yorke","year":"2019","journal-title":"Curr. Med. Res. Opin."},{"issue":"2","key":"10.1016\/j.bcmd.2021.102612_bb0180","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4314\/gmj.v50i2.1","article-title":"Pain services and prescription of opioid drugs in Ghana","volume":"50","author":"Boni","year":"2016","journal-title":"Ghana Med. J."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979621000784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979621000784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:36:25Z","timestamp":1761050185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979621000784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":35,"alternative-id":["S1079979621000784"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2021.102612","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2021.102612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102612"}}